510(k) K183151
K183151 is an FDA 510(k) premarket notification submitted by The Binding Site Group , Ltd. for the device "Optilite IgA CSF Kit". The FDA issued a decision of Substantially Equivalent on January 23, 2019. The device falls under product code CFN (Method, Nephelometric, Immunoglobulins (G, A, M)), a Class II device regulated under 21 CFR 866.5510. The Binding Site Group , Ltd. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- January 23, 2019
- Date Received
- November 14, 2018
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Method, Nephelometric, Immunoglobulins (G, A, M)
- Device Class
- Class II
- Regulation Number
- 866.5510
- Review Panel
- IM
- Submission Type